Communicating pharmacogenetic research results to breastfeeding mothers taking codeine: A pilot study of perceptions and benefits

P. Madadi; Y. Joly; D. Avard; D. C. Chitayat; M. A. Smith; C. J.D. Ross; B. C. Carleton; M. R. Hayden; G. Koren

doi:10.1038/clpt.2010.125

Communicating pharmacogenetic research results to breastfeeding mothers taking codeine: A pilot study of perceptions and benefits

P. Madadi, Y. Joly, D. Avard, D. C. Chitayat, M. A. Smith, C. J.D. Ross, B. C. Carleton, M. R. Hayden, G. Koren

Research output: Contribution to journal › Article › peer-review

24 Scopus citations

Abstract

Sixty-two codeine-prescribed breastfeeding mothers from a pharmacogenetic study were interviewed regarding the communication of individual CYP2D6 genotype results and overall research findings. All participants wanted to receive the results of their individual genetic tests; however, individuals placed different values on the usefulness of this information toward future medical decisions. Receiving one's pharmacogenetic test results was not associated with a negative psychosocial impact. Thirty-three percent of the participants wished to withhold these results from their physicians. Participants' expectations seem to dictate the extent of transparency of pharmacogenetic research results.

Original language	English
Pages (from-to)	792-795
Number of pages	4
Journal	Clinical Pharmacology and Therapeutics
Volume	88
Issue number	6
DOIs	https://doi.org/10.1038/clpt.2010.125
State	Published - Dec 2010
Externally published	Yes

Access to Document

10.1038/clpt.2010.125

Cite this

@article{c9733a171ab84ec29fd0d896a6d138ac,

title = "Communicating pharmacogenetic research results to breastfeeding mothers taking codeine: A pilot study of perceptions and benefits",

abstract = "Sixty-two codeine-prescribed breastfeeding mothers from a pharmacogenetic study were interviewed regarding the communication of individual CYP2D6 genotype results and overall research findings. All participants wanted to receive the results of their individual genetic tests; however, individuals placed different values on the usefulness of this information toward future medical decisions. Receiving one's pharmacogenetic test results was not associated with a negative psychosocial impact. Thirty-three percent of the participants wished to withhold these results from their physicians. Participants' expectations seem to dictate the extent of transparency of pharmacogenetic research results.",

author = "P. Madadi and Y. Joly and D. Avard and Chitayat, {D. C.} and Smith, {M. A.} and Ross, {C. J.D.} and Carleton, {B. C.} and Hayden, {M. R.} and G. Koren",

year = "2010",

month = dec,

doi = "10.1038/clpt.2010.125",

language = "אנגלית",

volume = "88",

pages = "792--795",

journal = "Clinical Pharmacology and Therapeutics",

issn = "0009-9236",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - JOUR

T1 - Communicating pharmacogenetic research results to breastfeeding mothers taking codeine

T2 - A pilot study of perceptions and benefits

AU - Madadi, P.

AU - Joly, Y.

AU - Avard, D.

AU - Chitayat, D. C.

AU - Smith, M. A.

AU - Ross, C. J.D.

AU - Carleton, B. C.

AU - Hayden, M. R.

AU - Koren, G.

PY - 2010/12

Y1 - 2010/12

N2 - Sixty-two codeine-prescribed breastfeeding mothers from a pharmacogenetic study were interviewed regarding the communication of individual CYP2D6 genotype results and overall research findings. All participants wanted to receive the results of their individual genetic tests; however, individuals placed different values on the usefulness of this information toward future medical decisions. Receiving one's pharmacogenetic test results was not associated with a negative psychosocial impact. Thirty-three percent of the participants wished to withhold these results from their physicians. Participants' expectations seem to dictate the extent of transparency of pharmacogenetic research results.

AB - Sixty-two codeine-prescribed breastfeeding mothers from a pharmacogenetic study were interviewed regarding the communication of individual CYP2D6 genotype results and overall research findings. All participants wanted to receive the results of their individual genetic tests; however, individuals placed different values on the usefulness of this information toward future medical decisions. Receiving one's pharmacogenetic test results was not associated with a negative psychosocial impact. Thirty-three percent of the participants wished to withhold these results from their physicians. Participants' expectations seem to dictate the extent of transparency of pharmacogenetic research results.

UR - http://www.scopus.com/inward/record.url?scp=78449298903&partnerID=8YFLogxK

U2 - 10.1038/clpt.2010.125

DO - 10.1038/clpt.2010.125

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 20739920

AN - SCOPUS:78449298903

SN - 0009-9236

VL - 88

SP - 792

EP - 795

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

IS - 6

ER -

Communicating pharmacogenetic research results to breastfeeding mothers taking codeine: A pilot study of perceptions and benefits

Abstract

Access to Document

Other files and links

Fingerprint

Cite this